Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties

Edith Poku, Rosie Duncan, Anju Keetharuth, Munira Essat, Patrick Phillips, Helen Buckley Woods, Simon Palfreyman, Georgina Jones, Eva Kaltenthaler, Jonathan Michaels, Edith Poku, Rosie Duncan, Anju Keetharuth, Munira Essat, Patrick Phillips, Helen Buckley Woods, Simon Palfreyman, Georgina Jones, Eva Kaltenthaler, Jonathan Michaels

Abstract

Background: Peripheral arterial disease (PAD) is generally associated with considerable morbidity and reduced quality of life. Patient-reported outcome measures (PROMs) provide important information about the burden of disease and impact of treatment in affected patients.

Objectives: The objective of the review was to identify and appraise studies reporting the psychometric evaluation of PROMs administered to a specified population of patients with PAD with a view to recommending suitable PROMs.

Methods: A systematic review of peer-reviewed English language articles was undertaken to identify primary studies reporting psychometric properties of PROMs in English-speaking patients with various stages of PAD. Comprehensive searches were completed up until January 2015. Study selection, data extraction and quality assessment were undertaken independently by at least two researchers. Findings were presented as tabular and narrative summaries based on accepted guidance.

Results: Psychometric evaluation of 6 generic and 7 condition-specific PROMs reported in 14 studies contributed data to the review. The frequently reported measure was the SF-36 (n = 11 studies); others included the Walking Impairment Questionnaire (n = 8 studies), EQ-5D (n = 5 studies) and the Vascular Quality of Life Questionnaire (n = 3 studies). Studies included a diverse PAD population and varied in methodology, including approach to validation of PROMs.

Conclusions: Various PROMs have been validated in patients with PAD but no study provided evidence of a full psychometric evaluation in the patient population. Careful selection is required to identify reliable and valid PROMs to use in clinical and research settings.

Keywords: Patient-reported outcome measures; Peripheral arterial disease; Psychometric; Systematic review; Validation.

Figures

Fig. 1
Fig. 1
Flow diagram of study selection here

References

    1. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr A. The routine use of patient reported outcome measures in healthcare settings. Br Med J. 2010;340:c186. doi: 10.1136/bmj.c186.
    1. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health technol assess. 1998;2(14):1–74.
    1. Health, Social Care Information. Finalised Patient Reported Outcome Measures (PROMs) In England: April 2011 to March 2012. 2014. Available at . Accessed 15 Nov 2016.
    1. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002;112(1):49–57. doi: 10.1016/S0002-9343(01)01034-8.
    1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608–1621. doi: 10.1056/NEJM200105243442108.
    1. Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, Sprangers MA, Blazeby JM. Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs) Trials. 2014;15:49. doi: 10.1186/1745-6215-15-49.
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.
    1. Jenkinson C, Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures in relation to stroke. 2009.
    1. Schellingerhout JM, Heymans MW, Verhagen AP, de Vet HC, Koes BW, Terwee CB. Measurement properties of translated versions of neck-specific questionnaires: a systematic review. BMC Med Res Methodol. 2011;11:87. doi: 10.1186/1471-2288-11-87.
    1. Emery MP, Perrier LL, Acquadro C. Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions. Health Qual Life Outcomes. 2005;3:12. doi: 10.1186/1477-7525-3-12.
    1. McKenna SP. Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med. 2011;9:86. doi: 10.1186/1741-7015-9-86.
    1. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549. doi: 10.1007/s11136-010-9606-8.
    1. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651–657. doi: 10.1007/s11136-011-9960-1.
    1. Morris C, Janssens A, Allard A, Thompson CJ, Shilling V, Tomlinson R, Williams J, Fellowes A, Rogers M, Allen K et al. Informing the NHS Outcomes Framework: evaluating meaningful health outcomes for children with neurodisability using multiple methods including systematic review, qualitative research, Delphi survey and consensus meeting. Health Serv Deliv Res. 2014;2(15).
    1. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi: 10.1016/j.jclinepi.2006.03.012.
    1. Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier PP. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest. 2002;122(3):920–929. doi: 10.1378/chest.122.3.920.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Second 1988.
    1. Smith MJ, Borchard KL, Hinton E, Scott AR. The Australian Vascular Quality of Life Index (AUSVIQUOL): an improved clinical quality of life tool for peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34(2):199–205. doi: 10.1016/j.ejvs.2007.02.005.
    1. Chetter IC, Spark JI, Dolan P, Scott DJ, Kester RC. Quality of life analysis in patients with lower limb ischaemia: suggestions for European standardisation. Eur J Vasc Endovasc Surg. 1997;13(6):597–604. doi: 10.1016/S1078-5884(97)80070-6.
    1. Chong PFS, Garratt AM, Golledge J, Greenhalgh RM, Davies AH. The intermittent claudication questionnaire: a patient-assessed condition-specific health outcome measure. J Vasc Surg. 2002;36(4):764–771. doi: 10.1016/S0741-5214(02)00131-3.
    1. Gulati S, Coughlin PA, Hatfield J, Chetter IC. Quality of life in patients with lower limb ischemia; revised suggestions for analysis. J Vasc Surg. 2009;49(1):122–126. doi: 10.1016/j.jvs.2008.08.011.
    1. Mehta T, Venkata SA, Chetter I, McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg. 2006;31(1):46–52. doi: 10.1016/j.ejvs.2005.08.028.
    1. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001;33(4):679–687. doi: 10.1067/mva.2001.112326.
    1. Tew G, Copeland R, Le Faucheur A, Gernigon M, Nawaz S, Abraham P. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg. 2013;57(5):1227–1234. doi: 10.1016/j.jvs.2012.02.073.
    1. Mazari FAK, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T, McCollum PT, Chetter IC. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease. J Vasc Surg. 2010;52(1):77–84. doi: 10.1016/j.jvs.2010.01.085.
    1. Coyne KS, Margolis MK, Gilchrist KA, Grandy SP, Hiatt WR, Ratchford A, Revicki DA, Weintraub WS, Regensteiner JG. Evaluating effects of method of administration on Walking Impairment Questionnaire. J Vasc Surg. 2003;38(2):296–304. doi: 10.1016/S0741-5214(03)00312-4.
    1. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, Katzel LI. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg. 2005;41(4):625–630. doi: 10.1016/j.jvs.2005.01.012.
    1. McDermott MM, Liu K, Guralnik JM, Martin GJ, Criqui MH, Greenland P. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg. 1998;28(6):1072–1081. doi: 10.1016/S0741-5214(98)70034-5.
    1. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 1990;2:142–152.
    1. Spertus J, Jones P, Poler S, Rocha-Singh K. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004;147(2):301–308. doi: 10.1016/j.ahj.2003.08.001.
    1. Treat-Jacobson D, Lindquist RA, Witt DR, Kirk LN, Schorr EN, Bronas UG, Davey CS, Regensteiner JG. The PADQOL: development and validation of a PAD-specific quality of life questionnaire. Vasc Med. 2012;17(6):405–415. doi: 10.1177/1358863X12466708.
    1. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS. Patient-reported outcomes: instrument development and selection issues. Value Health. 2007;10(Suppl 2):S86–S93. doi: 10.1111/j.1524-4733.2007.00271.x.
    1. Mahe G, Ouedraogo N, Vasseur M, Faligant C, Saidi K, Leftheriotis G, Abraham P. Limitations of self-reported estimates of functional capacity using the Walking Impairment Questionnaire. Eur J Vasc Endovasc Surg. 2011;41(1):104–109. doi: 10.1016/j.ejvs.2010.10.002.
    1. Mahe G, Ouedraogo N, Marchand J, Vielle B, Picquet J, Leftheriotis G, Abraham P. Self-reported estimation of usual walking speed improves the performance of questionnaires estimating walking capacity in patients with vascular-type claudication. J Vasc Surg. 2011;54(5):1360–1365. doi: 10.1016/j.jvs.2011.05.048.
    1. Conijn AP, Jens S, Terwee CB, Breek JC, Koelemay MJ. Assessing the quality of available patient reported outcome measures for intermittent claudication: a systematic review using the COSMIN checklist. Eur J Vasc Endovasc Surg. 2015;49(3):316–334. doi: 10.1016/j.ejvs.2014.12.002.
    1. Ouedraogo N, Mahe G, Marchand J, Saidi K, Leftheriotis G, Abraham P, et al. Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication. J Vasc Surg. 2011;54(1):133–8.
    1. Spengel FA, Lehert P, Dietze S. A statistical consideration of CLAU-S: a disease specific questionnaire for the assessment of quality of life in patients with intermittent claudication. VASA. 1998;27:253.
    1. Wann-Hansson C, Hallberg IR, Risberg B, Klevsgard R. A comparison of the Nottingham Health Profile and Short Form 36 Health Survey in patients with chronic lower limb ischaemia in a longitudinal perspective. Health Qual Life Outcomes. 2004;2:9. doi: 10.1186/1477-7525-2-9.
    1. Reeve BB, Wyrwich KW, Wu AW, Terwee CB, Synder CF, Schwartz C, Revicki DD, Monipour CM, McLeod LD, Lyons JC. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22:1889–1905. doi: 10.1007/s11136-012-0344-y.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere